Evidence map›Paper›PMID 40979472›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2025

Estimating the Prevalence and Severity of Isolated Small-Angle Strabismic Amblyopia.

Robert W Arnold

Abstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Robert W ArnoldAlaska Blind Child Discovery, Alaska Children's EYE & Strabismus, Anchorage, Alaska, 99508, USA.ORCID 0000-0002-5061-7717

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Isolated small-angle (< 20PD) strabismic amblyopia (is-asa) is not obvious to parents and pediatricians and can be missed by current photoscreeners. To improve early screening methods, the previously unknown prevalence and severity of is-asa is estimated from a twenty-year prospective observation. Methods: Published population data from the Multi-Ethnic and Baltimore Pediatric Eye Disease Studies (MEPEDS and BPEDS) were combined to estimate the cumulative prevalence. Then prospective, consecutive digital images of Brückner Test from 2003 to 2025 by one pediatric ophthalmologist were obtained with confirmatory exams. These were then compared to Alaska population and vision screening data. Results: From MEPEDS and BPEDS community screening data, patients with all strabismus, constant strabismus and strabismic amblyopia were stratified by strabismus angle suggesting that isolated small-angle strabismus (is-as) may occur in 1/200 children while is-asa may be 1/400 children. Over 22 years, 34 Alaska Brückner patients had isolated, constant strabismus less than 20 prism diopters of which 9 presented with amblyopia of which 4 had post-treatment residual amblyopia worse than 20/40. Considering population, doctors and referral rates, the Alaska prevalence of is-as is about 1 in 700 (0.03-0.24%) children while is-asa is about 1 in 7000 (0.006-0.024%) children. Conclusion: From two imperfect sources; review of large community screening studies and from prospective Brückner Test analysis, the prevalence of isolated small-angle strabismic amblyopia is so rare that future screening methods would require very high specificity. The Rebion blinq and 2WIN CR-function can identify is-asa in older children. Current photorefraction methods with early specific instrument referral criteria followed by sensitive acuity screening are still effective since is-asa is so rare.

Indexed as

amblyopiaBrücknerprevalencestrabismusvision screening

Identifiers

PMID40979472
PMCPMC12450028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.